(19)
(11) EP 3 755 319 A1

(12)

(43) Date of publication:
30.12.2020 Bulletin 2020/53

(21) Application number: 19756654.0

(22) Date of filing: 20.02.2019
(51) International Patent Classification (IPC): 
A61K 31/353(2006.01)
A61P 19/10(2006.01)
C07D 311/74(2006.01)
A61P 19/08(2006.01)
C07D 311/62(2006.01)
(86) International application number:
PCT/US2019/018730
(87) International publication number:
WO 2019/164914 (29.08.2019 Gazette 2019/35)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 20.02.2018 US 201815900533

(71) Applicant: Epirium Bio Inc.
San Diego CA 92122 (US)

(72) Inventors:
  • SCHREINER, George, F.
    Los Altos Hills, CA 94022 (US)
  • CEBALLOS, Guillermo
    Atizapan de Zaragoza Edo. de Mexico, 52998 (MX)
  • DUGAR, Sundeep
    San Jose, CA 95120 (US)

(74) Representative: King, Lawrence 
A.A. Thornton & Co. 15 Old Bailey
London EC4M 7EF
London EC4M 7EF (GB)

   


(54) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DISORDERS